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Abstract
Background: Viral hepatitis is a serious public health problem affecting billions of  people globally with maternal-fetal 
transmission on the rise. 
Objectives: This study sought to determine the prevalence and factors associated with hepatitis B virus (HBV) and hepatitis 
C virus (HCV) infections among pregnant women in the Asante Akim North Municipality, in the Ashanti region of  Ghana. 
Methods: In this cross-sectional study 168 pregnant women were recruited from the Agogo Presbyterian hospital. Blood 
samples were collected for the detection of  Hepatitis B Surface Antigen (HBsAg) and anti-HCV antibodies. A pretested 
questionnaire was used to obtain demographic data and identify the risk factors associated with the two infections. 
Results: Of  the 168 participants studied, 16 (9.5%) tested positive for HBV and 13 (7.7%) tested positive for HCV repre-
senting 9.5% and 7.7% respectively. A participant tested positive for both HBV and HCV co-infection representing 0.6%. 
Undertaking blood transfusion, tattooing and sharing of  needles were associated with hepatitis C infection (P=0.001). HBV 
was not associated with any of  the risk factors (P>0.05). 
Conclusion: Our findings suggest a high prevalence of  hepatitis B and hepatitis C among pregnant women; blood transfu-
sion, tattooing and sharing of  hypodermic needles were associated with hepatitis C infection. Measures to reduce the disease 
and transmission burden must be introduced. 
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Introduction
Hepatitis B virus (HBV) and hepatitis C virus (HCV) 
infections are serious public health issues with different 
prevalence rates worldwide. About one fifth of  the 2 
billion people infected with HBV across the globe have 
chronic infection1,2. World Health Organization (WHO) 
estimates indicate that about 200 million people have 
HCV infection across the globe3,4. HBV and HCV are 
contagious diseases that can be transmitted vertically 
from mothers to their neonates or horizontally through 
blood products and body secretions5. Mother-to- child 
transmission remains one of  the commonest routes by 
which HBV infection is contracted worldwide.6. The 
World Health Organization (WHO) estimates that 3% 
of  the world's population has chronic hepatitis C infec-
tion. Most of  these cases occur in Africa, which has the 
highest HCV infection prevalence rate7. Between 1999 
and 2002, an estimated 4.1 million people in the United 
States were infected with HCV, and of  these, 3.2 million 
had chronic infection8. 
Acute HBV infection during pregnancy is less severe 
and is not directly associated with increased mortality or 
teratogenicity9,10. However, increased incidences of  low 
birth weight and prematurity in infants born to mothers 
with acute HBV infection have been recorded9,11. Fur-
thermore, acute HBV infection in early pregnancy has 
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been associated with a 10% perinatal transmission rate 
11. Transmission rates (as high as 60%) have been re-
ported to increase significantly if  acute infection occurs 
at or near the time of  delivery10.
In light of  the aforementioned this study sought to 
determine the prevalence and factors associated with 
HBV and HCV infections among pregnant women at 
the Agogo Presbyterian hospital in the Ashanti region 
of  Ghana. Screening pregnant women for hepatitis B 
and C can give a reliable prevalence of  the disease in 
this population and provide an avenue for preventing 
mother to child transmission of  the virus.  
Subjects and methods
Study design/study site
This cross-sectional hospital based study was conduct-
ed at the Agogo Presbyterian hospital from December 
2012 to February 2013. The hospital is a referral cen-
tre located in the Asante Akim North District of  the 
Ashanti region of  Ghana. It provides antenatal and oth-
er specialized obstetric services for the inhabitants of  
the district and beyond. This district is a predominantly 
farming community.
Study population/sampling technique
The study population comprised all pregnant women 
receiving antenatal care at the Agogo Presbyterian hos-
pital, in the Asante Akim North municipality.  We used 
consecutive sampling to recruit 168 eligible pregnant 
women after we had explained the significance of  the 
study to the participants who visited the health facility 
within the study period. Women with a previous history 
of  any form of  liver disease, diabetes and pre-eclampsia 
were excluded from the study.
Socio-demographic data
We obtained informed written consent from partici-
pants of  the study and administered a pre-tested ques-
tionnaire to obtain socio-demographic and obstetric in-
formation,such as age, parity, educational background 
and marital status. Other data on the risk factors of  
possible routes of  transmission of  HBV and HCV like 
sharing of  toothbrush, haemodialysis treatment, his-
tory of  abortions, multiple sexual partners, history of  
previous blood transfusions and other blood products, 
history of  intravenous drug use, history of  tattooing, 




Three milliliters (3mls) of  venous blood was collected 
from each participant through venipuncture, dispensed 
into serum separator tubes, allowed to clot and cen-
trifuged at a relative centrifugal force (RCF) of  1000-
1500g for 10 minutes. The serum aliquots were stored 
at -20OC until ready for use. 
HBV and HCV testing
Separate strips (Dia Spot Rapid One-step Test Strip, 
United Kingdom) were used to detect HBsAg and an-
ti-HCV antibodies in the serum of  participants in ac-
cordance with the manufacturers’ instructions. 
Statistical analysis 
Data was entered into Excel worksheet and analyzed 
using SPSS version 16 (Statistical Package for Social 
Sciences). Also Chi – square model was conducted to 
determine the significance of  the associations between 
the possible risk factors and their infections due to the 
non –parametric nature of  the data P-value <0.05 was 
considered significant.
Ethical approval 
Ethical consent was sought from the Institutional Re-
view Board of  the University Cape Coast (UCCIRB) 
and the hospital ethical committee. Informed consent 
was obtained from each participant prior to commence-
ment of  the study.
  
Results
Table 1 shows the prevalence of  HBV and HCV infec-
tion among the study participants. For HBV 16 partic-
ipants (9.5%) tested positive whereas 13 (7.7%) tested 
positive for HCV. Only 1 participant (0.6%) had mixed 
infection of  HbsAg and HCV. 
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Table 2 shows the factors associated with HBV and 
HCV infection among the study participants. None 
of  the risk factors showed a significant association 
with HBV infection.  However, blood transfusion 
(OR=13.91; P=0.012), tattooing and sharing of  nee-
dles (OR=7.21; P=0.004) were associated with HCV 
infection. Factors such as diagnosis with STD’S, history 
of  healthcare needle stick injury, exposure to human 
blood, and family history of  HCV were not significant-
ly associated with HCV infection  (P>0.05). 
Table 2: Factors predisposing participants to hepatitis B and hepatitis C infections
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Table 1: Baseline characteristics of participants and prevalence of viral hepatitis 
infection 
Variable N (%) 
 
(n = 168) 
Age group n (%) 
 10-14 2 (1.2) 
15-19 12 (7.1) 
20-24 43 (25.6) 
25-29 55 (32.7) 
30-34 30 (17.9) 
35-40 26 (15.5) 
Education n (%) 
 None 15 (8.9) 
Primary 105 (62.5) 
Secondary 24 (14.3) 
Tertiary 24 (14.3) 
Occupation n (%) 
 None 30 (17.9) 
Formal 17 (10.1) 
Informal 121 (72.0) 
Hepatitis Status n (%)   
HBV 
 Positive 16 (9.5) 
Negative 152 (90.5) 
HCV 
 Positive 13 (7.7) 
Negative 155 (92.3) 
HBV + HCV 
 Positive 1 (0.6) 
Negative 167 (99.4) 




  HCV 
 
 




OR (95% CI) P-value 








2.83 (0.89-8.97) 0.077 
No *                             1* 
 
  1* 
 Multiple Sexual partners   
  
  
  Yes* 1* 
 
  1* 
 No                                        1*  
  
 
Receipt of clotting factor concentrates 
  
 
  Yes* 1* 
 






0.09 (0.00-4.55) 0.226 




  Yes* 1* 
 






0.09 (0.00-4.55) 0.226 
 
Due to  the fact that most of  the participants answered 
no to exposure to some risk factors (multiple sexu-
al partners, haemodialysis treatment, usage of  illegal 
drugs, sharing of  toothbrush with HCV affected per-
son, receiving blood clotting factors concentrates and 
contact with blood or open sores), no association was 
found to exist between such factors and HCV infection. 
Discussion
HBV and HCV infections are both contagious diseases 
that can be transmitted vertically from mothers to  their 
neonates or horizontally through blood products and 
body secretions5. This study determined the prevalence 
and risk factors associated with hepatitis B and C in-
fection among pregnant women in the Ashanti Akim-
north municipality in the Ashanti region of  Ghana. The 
study revealed 9.5% and 7.7% prevalence of  hepatitis 
B and hepatitis C infection respectively among the par-
ticipants. Only one participant (0.6%) was a carrier of  
both viruses. Also, no association was found between 
hepatitis B infections and the risk factors. Blood trans-
fusion, tattooing, body piercing and sharing of  needles 
were associated with transmission of  hepatitis C virus 
infection among the participants. 
The prevalence observed in this study is consistent with 
the findings of  earlier studies which reported a higher 
hepatitis B infection rate than hepatitis C among preg-
nant women in Nigeria12. The above findings are also 
similar to the study of  Murad et al13, who recorded a 
prevalence of  10.8%, 8.5% and 0% of  HBV, HCV and 
HBV-HCV co-infection respectively among 400 par-
ticipants in Saana Yemen. However, our prevalence is 
higher than the 5% and less than one percent record-
ed in studies in Sudan7. The prevalence in our study 
is higher because we used immunochromatographic 
methods whereas ELISA technique was used in the Su-
danese study. Immunochromatographic methods have 
lower specificity compared to the more specific ELISA 
techniques. In contrast with earlier studies in Sudan7 
and Malawi14 0.6% of  our participants had both HCV 
and HBV infection. 
The prevalence of  hepatitis C infection in this study 
was higher (7.7%) than the prevalence (0.2% and 
6.25%) reported in Lorestan (West of  Iran) and Ah-
vaz by Mohebbi et al.,5 and Motlagh et al,15 respectively. 
These inconsistencies could be attributed to the differ-
ences in sample size as well as the fact that Mohebbi 
et al., conducted their study across multiple centres in 
rural and urban communities whereas our single-centre 
study was conducted in a predominantly rural commu-
nity. Moreover, in the cross-sectional study by Mohebbi 
et al,5 samples were first screened for anti-HBc and an-
ti-HCV using commercially available ELISA kits before 
those which were reactive for anti-HBc were tested for 
HBsAg. Similarly, the prevalence rate of  HBV infection 
recorded in this study is higher than that observed in 
earlier studies among pregnant women in Sudan16, Sau-
di Arabia17 and Libya18. Geographical differences have 
been identified as the main reason for the variation of  
seroprevalence rates of  HBV infection among pregnant 
women in different countries19. Furthermore, as in the 
studies in Lorestan and Ahaz, positive cases in Egypt, 
Saudi Arabia and Libya were confirmed with ELISA 
techniques. However, studies conducted by Eke et al,20 
from Nigeria recorded a prevalence (8.3%) comparable 
with what is recorded in our study. 
In consonance with earlier studies21, we observed a sig-
nificant association between some risk factors (tatooing 
and body piercing, history of  sharing of  hypodermic 
needles and blood transfusion) and HCV infection. 
Ward et al.,21 had earlier identified an association be-
tween illicit drug use and body piercing (chiefly for ear 
rings) and HCV infection in the multiethnic population 
in London. In agreement with the findings of   Eke et 
al,20 and Akani et al,22 from studies conducted in Nnewi 
and Port Harcourt respectively, we recorded no signif-
icant association between hepatitis B infection and the 
risk factors.  Interestingly, this observation contradicts 
the results of  studies conducted in Nigeria and Pales-
tine23,24. Though no reason could readily be assigned for 
this observation, the small sample size employed in this 
study coupled with the method of  testing for the infec-
tion could account for the lack of  association between 
hepatitis B infection and the risk factors.
The outcome of  this study justifies the establishment 
of  a national HBV and HCV screening program for all 
pregnant women in antenatal clinics throughout Ghana. 
In addition, a national policy to vaccinate all pregnant 
women who test negative for hepatitis B must be adopt-
ed so as to reduce the risk of  mother to child transmis-
sion within the population. Although this study is rele-
vant it has major limitations. Investigation into a similar 
population of  non-pregnant women to compare the 
findings was not done. Also, the study did not employ 
ELISA for the sero-analysis but rather used rapid test 
strips which may not yield 100% accuracy especially for 
HCV. Furthermore, the viral load was not determined 
for HBV and HCV positive pregnant women.  
Conclusion
The prevalence of  HBV and HCV infection in this 
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study was 9.5% and 7.7% respectively. History of  shar-
ing hypodermic needles, tattooing and body piercing, 
and blood transfusion were associated with HCV infec-
tion. The Ghana Health Service policy of  screening all 
pregnant women in Ghana during their routine antena-
tal visit is therefore justified and a policy to vaccinate 
women who test negative for HBV must be promulgat-
ed to reduce the future risk of  mother to child trans-
mission.
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